Literature DB >> 4352631

Oat-cell carcinoma of the lung simultaneously producing ACTH and serotonin.

R Horai, H Nishihara, R Tateishi, M Matsuda, S Hattori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352631     DOI: 10.1210/jcem-37-2-212

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  7 in total

1.  Demonstration of argyrophil granules in small cell carcinoma of the lung.

Authors:  R Tateishi; T Horai; S Hattori
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-03-10

Review 2.  Cell differentiation and the biological significance of inappropriate tumour products.

Authors:  M L Ellison
Journal:  Proc R Soc Med       Date:  1977-12

3.  Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung.

Authors:  M Hansen; M Hammer; L Hummer
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

Review 4.  Shaping future strategies for the pharmacological control of tumor cell metastases.

Authors:  R G Greig; D L Trainer
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

Review 5.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

6.  Lung tumour cell lines synthesizing peptide hormones established from tumours of four histological types: characterization of the cell lines and analysis of their peptide hormone production.

Authors:  W Luster; C Gropp; H F Kern; K Havemann
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

7.  Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report.

Authors:  Andrea Casadei Gardini; Marita Mariotti; Alessandro Lucchesi; Sara Pini; Martina Valgiusti; Sara Bravaccini; Angelo Del Monte; Marco Angelo Burgio; Giorgia Marisi; Dino Amadori; Giovanni Luca Frassineti
Journal:  BMC Cancer       Date:  2016-02-17       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.